申请人:Butora Gabor
公开号:US20070155731A1
公开(公告)日:2007-07-05
Compounds of Formula I and Formula II (wherein A, E, j, k, m, n, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
15
, R
16
, R
17
, R
18
, R
19
, R
24
, R
25
, R
26
, R
27
, R
28
, R
29
, R
30
, R
31
, R
32
, R
33
, R
34
, X, Y and Z are as defined herein) which are modulators of chemokine receptor activity and are useful in the prevention or treatment of certain inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which chemokine receptors are involved.
化合物的化学式I和化学式II(其中A、E、j、k、m、n、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R15、R16、R17、R18、R19、R24、R25、R26、R27、R28、R29、R30、R31、R32、R33、R34、X、Y和Z如本文所定义)是化学受体活性调节剂,可用于预防或治疗某些炎症和免疫调节性疾病,过敏性疾病,包括过敏性鼻炎、皮炎、结膜炎和哮喘,以及类风湿关节炎和动脉粥样硬化等自身免疫病理。该发明还涉及包含这些化合物的药物组合物以及在涉及化学受体的疾病的预防或治疗中使用这些化合物和组合物。